Johnson & Johnson (JNJ)
NYSE
Healthcare
Drug Manufacturers - General
$225.33
▼ -2.37%
Market Cap
$542.42B
Sector
Healthcare
Industry
Drug Manufacturers - General
Beta
0.26
52-Wk Range
149.04-251.71
CEO
Joaquin Duato
Country
US
Currency
USD
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various canc…
Open full interactive analysis & DCF →